Cheng-Xue Pan

Dr. Cheng-Xue Pan

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 June 2022 in Organic & Biomolecular Chemistry
Verified
Journal Article
Closed access
PDF file
WWWang Wang
Wang Wang
PZPei-Sen Zou
Pei-Sen Zou
LPLi Pang
Li Pang
CPCheng-Xue Pan
Cheng-Xue Pan
DMDong-Liang Mo
Dong-Liang Mo
GSGui-Fa Su
Gui-Fa Su
As one of the most important structural units in pharmaceuticals and medicinal chemistry, quinazolinone and its derivatives exhibit a wide range of biological and pharmacological activities, including anti-inflammatory, antitubercular, antiviral, and anticancer activities, etc. In particular, 2,3-fused quinazolinones have attracted much attention because the rings fused to the 2,3-positions of quinazolinones improve their rigidity and planarity. Their synthetic strategies have made great advances in recent years. Therefore, this review focuses on novel strategies for the synthesis of 2,3-fused quinazolinone derivatives from 2017 to 2022, such as the difunctionalization of alkenes, the ring-opening of easily available small rings, dehydrogenative cross-coupling reactions, transition-metal catalyzed cyclizations, cycloadditions, and other cascade reactions.

15 August 2017 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
GZGuo-Hai Zhang
Guo-Hai Zhang
JYJing-Mei Yuan
Jing-Mei Yuan
GQGang Qian
Gang Qian
CGChen-Xi Gu
Chen-Xi Gu
KWKai Wei
Kai Wei
GSGui-Fa Su
Gui-Fa Su

1 March 2019 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
QLQing-Qing Liu
Qing-Qing Liu
KLKe Lu
Ke Lu
HZHai-Miao Zhu
Hai-Miao Zhu
SKShi-Lin Kong
Shi-Lin Kong
JYJing-Mei Yuan
Jing-Mei Yuan
GSGui-Fa Su
Gui-Fa Su

1 May 2015 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
GZGuo-Hai Zhang
Guo-Hai Zhang
WXWen-Bin Xue
Wen-Bin Xue
YAYun-Feng An
Yun-Feng An
JYJing-Mei Yuan
Jing-Mei Yuan
JQJiang-Ke Qin
Jiang-Ke Qin
GSGui-Fa Su
Gui-Fa Su

1 January 2020 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
XWXin-Wei Wei
Xin-Wei Wei
JYJing-Mei Yuan
Jing-Mei Yuan
WHWan-Yun Huang
Wan-Yun Huang
NCNan-Ying Chen
Nan-Ying Chen
XLXiao-Juan Li
Xiao-Juan Li
GSGui-Fa Su
Gui-Fa Su

18 June 2020 in Organic Chemistry Frontiers
Verified
Journal Article
Closed access
PDF file
XKXiang-Fei Kong
Xiang-Fei Kong
XGXiu-Yun Guo
Xiu-Yun Guo
ZGZi-Yu Gu
Zi-Yu Gu
LWLin-Su Wei
Lin-Su Wei
LLLu-Lu Liu
Lu-Lu Liu
GSGui-Fa Su
Gui-Fa Su
We report a silver-catalyzed hydroalkoxylation of C2-alkynyl quinazolinones to prepare a series of novel quinazolinone-fused eight-membered N,O-heterocycles in good-to-excellent yields through a selective 8-endo-dig cyclization. Mechanistic studies revealed that the silver catalyst might aid bidentate coordination of an imine group and alkyne to facilitate 8-endo-dig cyclization to afford eight-membered N,O-heterocycles. Also, the proposed bimetal silver intermediates might promote hydroalkoxylation rapidly for quinazolinones bearing terminal alkynes at the C2-position. Biological evaluations revealed that most of the designed quinazolinone-fused eight-membered N,O-heterocycles inhibited nitric-oxide generation significantly in lipopolysaccharide-stimulated RAW264.7 cells and displayed their bioactivity as potentially good anti-inflammatory agents.